Ophthalmology

Eye Specialists Question Value of Pricey Cataract Lenses

European ophthalmologists are raising concerns about the increasing use and cost of premium intraocular lenses in cataract surgery, citing limited evidence of superior patient outcomes.

Surgical Start Time Does Not Impact Cataract Complication Rates

New research indicates that the time of day cataract surgery begins has no bearing on postoperative complication rates, challenging long-held assumptions.

Presbyopia Treatment Needs Personalisation, Not One-Size-Fits-All

Patient-specific factors dictate satisfaction with presbyopia-correcting intraocular lenses, with preoperative simulation tools emerging to tailor treatment.

Urcosimod Enters Phase 3 for Neuropathic Corneal Pain

Urcosimod, an investigational therapy, will advance to Phase 3 trials to evaluate its efficacy in treating neuropathic corneal pain, addressing a significant unmet clinical need.

Neuroadaptation Key to Presbyopia-Correcting IOL Success, Specialist Says

Neuroadaptation plays a critical role in patient satisfaction and visual outcomes following presbyopia-correcting IOL implantation, a specialist explained. The brain's ability to adjust to new optical input determines functional vision.

MIGS Integration in Cataract Surgery Improves IOP Control

Integrating minimally invasive glaucoma surgery (MIGS) with cataract extraction offers superior intraocular pressure control for patients with coexisting glaucoma.

Xiidra Leads Most Patients to 'Clinically Meaningful' Eye Dryness Reduction

Lifitegrast (Xiidra) significantly reduced eye dryness symptoms in a majority of patients with dry eye disease, offering a new therapeutic option.

Single Sura-vec Injection Improved Early Diabetic Retinopathy

A single intravitreal injection of sura-vec demonstrated improvements in early diabetic retinopathy, offering a potential new therapeutic avenue for patients.

New Glaucoma Care Restriction: IOP Targets and Treatment Access

A recent policy change limiting glaucoma treatment options warrants scrutiny, potentially impacting intraocular pressure management and patient outcomes.